Tag Archives: Deutsche Bank

Merck Shows Off Bevy of New Drugs

Image by Chemical Heritage Foundation via Flickr While Merck’s net profits might be a little low in the wake of the Schering-Plough merger, it’s pipeline—and future sales—are far from bleak. According to a new report from analyst firm Deutsche Bank, Merck has no less than 18 drugs in Phase III development, with three slated for […]
Posted in R&D, Strategy | Also tagged , , , , , | Leave a comment
  • Categories

  • Meta